These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15612876)

  • 1. A critical assessment of the European Commission's proposals for the risk assessment and registration of chemical substances in the European Union.
    Combes R; Dandrea J; Balls M
    Altern Lab Anim; 2003; 31(3):353-64. PubMed ID: 15612876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical assessment of the European Commission's proposals for the risk assessment and registration of chemical substances in the European Union.
    Combes R; Dandrea J; Balls M
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():29-40. PubMed ID: 16555958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of stakeholder organisations on the proposed new European chemicals policy.
    Dandrea J; Combes RD
    Altern Lab Anim; 2003 Nov; 31(5):501-28. PubMed ID: 15598177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prospects for using (Q)SARs in a changing political environment--high expectations and a key role for the European Commission's joint research centre.
    Worth AP; Van Leeuwen CJ; Hartung T
    SAR QSAR Environ Res; 2004; 15(5-6):331-43. PubMed ID: 15669693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the European centre for the validation of alternative methods (ECVAM) in the validation of (Q)SARs.
    Worth AP; Hartung T; Van Leeuwen CJ
    SAR QSAR Environ Res; 2004; 15(5-6):345-58. PubMed ID: 15669694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():1-6. PubMed ID: 19025328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the European Chemicals Bureau in promoting the regulatory use of (Q)SAR methods.
    Worth AP; Bassan A; De Bruijn J; Gallegos Saliner A; Netzeva T; Patlewicz G; Pavan M; Tsakovska I; Eisenreich S
    SAR QSAR Environ Res; 2007; 18(1-2):111-25. PubMed ID: 17365963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European Commission's White Paper "strategy for a future chemicals policy": a review.
    Rogers MD
    Risk Anal; 2003 Apr; 23(2):381-8. PubMed ID: 12731821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A scientific and animal welfare assessment of the OECD Health Effects Test Guidelines for the safety testing of chemicals under the European Union REACH system.
    Combes RD; Gaunt I; Balls M
    Altern Lab Anim; 2004 Sep; 32(3):163-208. PubMed ID: 15588165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [White Paper of the European Commission--strategy for a new chemicals policy].
    Spielmann H
    ALTEX; 2002; 19 Suppl 1():20-5. PubMed ID: 12096326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overall strategy for the testing of chemicals for human hazard and risk assessment under the EU REACH system.
    Combes R; Barratt M; Balls M
    Altern Lab Anim; 2003; 31(1):7-19. PubMed ID: 16221040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FRAME and the Royal Commission on Environmental Pollution: common recommendations for assessing risks posed by chemicals under the EU REACH system.
    Combes RD; Dandrea J; Balls M
    Altern Lab Anim; 2003 Nov; 31(5):529-35. PubMed ID: 15598178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Commission White Paper on a Strategy for a Future EU Chemicals Policy: the view of European companies of American parentage.
    Montfort JP
    Risk Anal; 2003 Apr; 23(2):399-404. PubMed ID: 12731823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical evaluation of the 2011 ECHA reports on compliance with the REACH and CLP regulations and on the use of alternatives to testing on animals for compliance with the REACH regulation.
    Spielmann H; Sauer UG; Mekenyan O
    Altern Lab Anim; 2011 Oct; 39(5):481-93. PubMed ID: 22103941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences of the REACH testing proposals system to reduce animal testing.
    Taylor K; Stengel W; Casalegno C; Andrew D
    ALTEX; 2014; 31(2):107-28. PubMed ID: 24609452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of stakeholder organisations on the proposed new European chemical policy.
    Dandrea J; Combes R
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():41-68. PubMed ID: 16555959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating process safety with molecular modeling-based risk assessment of chemicals within the REACH regulatory framework: benefits and future challenges.
    Lewis A; Kazantzis N; Fishtik I; Wilcox J
    J Hazard Mater; 2007 Apr; 142(3):592-602. PubMed ID: 16930827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new EU Chemicals Policy--comments of Eurogroup for Animal Welfare and the Deutscher Tierschutzbund on the EU-Commission's REACH system Consultation Documents.
    Sauer UG
    ALTEX; 2003; 20(3):225-7. PubMed ID: 12947488
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrated testing strategy (ITS) for bioaccumulation assessment under REACH.
    Lombardo A; Roncaglioni A; Benfentati E; Nendza M; Segner H; Fernández A; Kühne R; Franco A; Pauné E; Schüürmann G
    Environ Int; 2014 Aug; 69():40-50. PubMed ID: 24806447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.